Common Constipation Drug Shows Power to Protect Kidneys

Medical Discovery in Common Drug

A common constipation drug may have unexpectedly unlocked a new way to slow chronic kidney disease — a condition that affects millions and often leads to dialysis. In a clinical trial involving 150 patients, researchers found that lubiprostone, a medication typically used for gastrointestinal complaints, demonstrated unexpected benefits for kidney health.

This serendipitous finding highlights how existing medications sometimes harbor undiscovered therapeutic uses, potentially offering hope to the millions suffering from chronic kidney disease while providing a more affordable treatment option.